Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...
Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct ...
A natural vitamin A transporter, RBP4, can awaken latent HIV through NF-κB signalling, offering a new angle for cure ...
Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even after treatment. But, thanks to a new class of drugs, its luck ...
The data demonstrated that finite-duration 24-week AHB-137 monotherapy achieved a 30% functional cure rate at Week 72 (EOF) in patients with baseline HBsAg 100--1,000 IU/mL. This finding strengthens ...
Study shows DAAs and interferon offer similar long-term protection against hepatocellular carcinoma after hepatitis C cure ...
In 1981, physicians in Los Angeles reported five young patients with Pneumocystis pneumonia, a rare lung infection later recognized as the first sign of HIV infection and a defining illness of AIDS.
No cure is available for some sexually transmitted infections (STIs), such as HIV, human papillomavirus (HPV), herpes, and hepatitis B. However, treatment can help reduce the effects of these ...
ST. LOUIS – Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even after treatment. But, thanks to a new class of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback